Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease metabolic syndrome x
Comorbidity C0042373|vascular disease
Sentences 75
PubMedID- 21808142 Cd36 deficiency is related to phenotypic expression of the metabolic syndrome, frequently associated with atherosclerotic cardiovascular diseases resulting in raised levels of glucose thereby contributing to type 2 diabetes (t2dm).
PubMedID- 24856006 Objectives since oils and fats can induce metabolic syndrome, leading to cardiovascular and cerebrovascular diseases, the present study was performed to find out whether the plant oils affect the cerebral hemorrhage in stroke-prone spontaneously hypertensive (shr-sp) rats.
PubMedID- 21679922 Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome.
PubMedID- 22760893 Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases.
PubMedID- 24705461 Aids-related lymphoma (arl), metabolic syndromes (including cardiovascular diseases, cvds; atherosclerosis and other lipid disorders), and hiv-associated dementia (had) – can be considered as all macrophage-mediated disorders in which nef is an unquestioned key factor [10].
PubMedID- 24926685 Nafld is a risk factor for cardiovascular diseases and is associated with metabolic syndrome.
PubMedID- 22682107 Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit.
PubMedID- 20609696 In addition, hypertension is an important contributor to increasing cardiovascular disease risk in patients with the cardiometabolic syndrome.
PubMedID- 25957218 Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease.
PubMedID- 20349347 The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities.
PubMedID- 22417460 High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components.
PubMedID- 21841320 Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd).
PubMedID- 21123363 The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow delivery/distribution and local metabolism.
PubMedID- 25541285 The insulin-like growth factor i system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome.
PubMedID- 21785705 Finally, there is some evidence that support an important role of mineralocorticoid receptor blockers in the treatment of resistant hypertension and in the prevention of cardiovascular diseases in patients with metabolic syndrome and type 2 diabetes mellitus.
PubMedID- 24498934 Relation between ev-markers and metabolic syndrome in patients with manifest cardiovascular disease.
PubMedID- 21766575 [the association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study].
PubMedID- 23334870 This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting.
PubMedID- 26485682 Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4].
PubMedID- 19781706 There is ample epidemiological evidence linking obesity, and the related ‘metabolic syndrome’, with vascular disease [1].
PubMedID- 19958158 Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress.
PubMedID- 25633268 Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd).
PubMedID- 22205060 The emphasis on diagnosing and treating the individual risk factors should help in the prevention of the cardiovascular disease associated with obesity, the metabolic syndrome and type 2 diabetes.
PubMedID- 21750749 In addition to type 2 dm and cardiovascular disease, patients with insulin resistance syndrome are at higher risk for bph [20].
PubMedID- 20553596 Given the prognostic significance of the metabolic syndrome in patients with vascular disease, we evaluated the association of vfa, sfa and lfp with metabolic syndrome in a high-risk vascular cohort.
PubMedID- 21318102 Increasing plasma apn or enhancing apn signal transduction may be an ideal strategy to prevent and treat the cardiovascular diseases associated with metabolic syndrome.
PubMedID- 26543549 This frequent association of type b insulin resistance syndrome with collagen vascular diseases aggravates the clinical situation due to the presence of anti-insulin antibodies that prevent treatment of hyperglycemia, even with large doses of insulin.
PubMedID- 21516134 Although several studies have reported that the chemerin/chemr23 axis is strongly associated with cardiovascular disease and aspects of metabolic syndrome11, 26, 27, there was no direct evidence for the role of the chemerin/chemr23 axis in maintaining endothelial function.
PubMedID- 23873328 Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure.
PubMedID- 24453423 Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us [27–29], ethnicity did not impact the il-6-endothelial activation relationship in the present investigation.
PubMedID- 20689417 Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease.
PubMedID- 25916279 Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome.
PubMedID- 24716162 It is also strongly related to other pathological conditions, including obesity, diabetes, cardiovascular diseases, and symptoms of metabolic syndrome.
PubMedID- 20508159 The hypothesis that rimonabant has protective effects against vascular disease associated with the metabolic syndrome was tested using jcr:la-cp rats.
PubMedID- 20671994 On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome.
PubMedID- 24624345 Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome [4], is associated with kidney disease, cardiovascular disease [5], cerebrovascular disease [6], obesity, diabetes, hypertriglyceridemia, and hypertension.
PubMedID- 20509277 Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction).
PubMedID- 20300596 Depression is an independent risk factor for cardiovascular diseases and is associated with metabolic syndrome (mets).
PubMedID- 22916265 The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity.
PubMedID- 25247821 These findings have important public health implications due to the known cardiovascular disease risk factors associated with metabolic syndrome.
PubMedID- 24708775 In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia [32,37].
PubMedID- 20823276 Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome.
PubMedID- 24396692 Furthermore, nafld is emerging as a risk factor for diabetes and cardiovascular disease, independently of insulin resistance, metabolic syndrome, plasma lipid level, and other traditional risk factors [2].
PubMedID- 24844874 Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn).
PubMedID- 23257741 [chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches].
PubMedID- 20488778 In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome.
PubMedID- 21466628 Based on the increased cardiovascular disease risk of the metabolic syndrome, which is similar to stage 1 hypertension, both lifestyle modification and arb therapy are justifiable.
PubMedID- 26525819 Thus, primary and secondary prevention of cerebrovascular disease in patients with metabolic syndrome should include haemangiocorrective, antithrombotic, antioxidant and endothelium-protective treatment, as well as therapy of the main components of metabolic syndrome.
PubMedID- 25857370 Background and purpose: increased level of very low-density lipoprotein (vldl) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases.
PubMedID- 25918936 The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation [2,5].

Page: 1 2